AAAAAA

   
Results: 1-15 |
Results: 15
Screening for renal disease using serum creatinine: who are we missing?
Authors: Duncan, L Heathcote, J Djurdjev, O Levin, A
Citation: L. Duncan et al., Screening for renal disease using serum creatinine: who are we missing?, NEPH DIAL T, 16(5), 2001, pp. 1042-1046
Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin
Authors: Jain, K Lam, WC Waheeb, S Thai, Q Heathcote, J
Citation: K. Jain et al., Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin, BR J OPHTH, 85(10), 2001, pp. 1171-1173
On personal development plans
Authors: Heathcote, J
Citation: J. Heathcote, On personal development plans, BR J GEN PR, 50(459), 2000, pp. 846-847
Update on primary biliary cirrhosis
Authors: Heathcote, J
Citation: J. Heathcote, Update on primary biliary cirrhosis, CAN J GASTR, 14(1), 2000, pp. 43-48
Antiviral therapy for patients with chronic hepatitis C
Authors: Heathcote, J
Citation: J. Heathcote, Antiviral therapy for patients with chronic hepatitis C, SEM LIV DIS, 20(2), 2000, pp. 185-199
A la carte interferon for hepatitis C?
Authors: Marcellin, P Benhamou, JP Heathcote, J Bismuth, H Desmet, V Guardia, J Lok, A Zum Buschenfeld, KHM Pagliaro, L Paumgartner, G Rodes, J Sherlock, S
Citation: P. Marcellin et al., A la carte interferon for hepatitis C?, HEPATOLOGY, 32(3), 2000, pp. 678-678
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial
Authors: Schalm, SW Heathcote, J Cianciara, J Farrell, G Sherman, M Willems, B Dhillon, A Moorat, A Barber, J Gray, DF
Citation: Sw. Schalm et al., Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial, GUT, 46(4), 2000, pp. 562-568
Influence of vitamin D receptor gene polymorphism on bone mineral density in primary biliary cirrhosis - Reply.
Authors: Rubin, L Cole, D Springer, J Heathcote, J
Citation: L. Rubin et al., Influence of vitamin D receptor gene polymorphism on bone mineral density in primary biliary cirrhosis - Reply., GASTROENTY, 119(2), 2000, pp. 599-600
Oral prostaglandin (PGE(2)) therapy for chronic viral hepatitis B and C
Authors: Hyman, A Yim, C Krajden, M Read, S Basinski, ASH Wanless, I Levy, G Heathcote, J
Citation: A. Hyman et al., Oral prostaglandin (PGE(2)) therapy for chronic viral hepatitis B and C, J VIRAL HEP, 6(4), 1999, pp. 329-336
A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus
Authors: Heathcote, J McHutchison, J Lee, S Tong, M Benner, K Minuk, G Wright, T Fikes, J Livingston, B Sette, A Chestnut, R
Citation: J. Heathcote et al., A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus, HEPATOLOGY, 30(2), 1999, pp. 531-536
No association between hepatitis C and B-cell lymphoma
Authors: Collier, JD Zanke, B Moore, M Kessler, G Krajden, M Shepherd, F Heathcote, J
Citation: Jd. Collier et al., No association between hepatitis C and B-cell lymphoma, HEPATOLOGY, 29(4), 1999, pp. 1259-1261
Efficacy of lamivudine in patients with hepatitis B e antigen-negative hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B
Authors: Tassopoulos, NC Volpes, R Pastore, G Heathcote, J Buti, M Goldin, RD Hawley, S Barber, J Condreay, L Gray, DF
Citation: Nc. Tassopoulos et al., Efficacy of lamivudine in patients with hepatitis B e antigen-negative hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B, HEPATOLOGY, 29(3), 1999, pp. 889-896
Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis
Authors: Pasha, T Heathcote, J Gabriel, S Cauch-Dudek, K Jorgensen, R Therneau, T Dickson, ER Lindor, KD
Citation: T. Pasha et al., Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis, HEPATOLOGY, 29(1), 1999, pp. 21-26
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
Authors: Alvarez, E Berg, PA Bianchi, FB Bianchi, L Burroughs, AK Cancado, EL Chapman, RW Cooksley, WGE Czaja, AJ Desmet, VJ Donaldson, RT Eddleston, ALWF Fainboim, L Heathcote, J Homberg, JC Hoofnagle, JH Kakumu, S Krawitt, EL Mackay, IR MacSween, RNM Maddrey, WC Manns, MP McFarlane, IG zum Buschenfelde, KHM Mieli-Vergani, G Nakanuma, Y Nishioka, M Penner, E Porta, G Portmann, BC Reed, WD Rodes, J Schalm, SW Scheuer, PJ Schrumpf, E Seki, T Toda, G Tsuji, T Tygstrup, N Vergani, D Zeniya, M
Citation: E. Alvarez et al., International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis, J HEPATOL, 31(5), 1999, pp. 929-938
EASL International Consensus Conference on Hepatitis C - Paris, 26-27 February 1999 - Consensus statement (Reprinted from Journal of Hematology, vol 30, pg 956-961, 1999)
Authors: Marcellin, P Alberti, A Dusheiko, G Esteban, R Manns, M Shouval, D Weiland, O Williams, R Benhamou, JP Rodes, J Alter, H Bismuth, H Desmet, V Guardia, J Heathcote, J Lok, A Maddrey, WC Zum Buschenfelde, KHM Pagliaro, L Paumgartner, G Sherlock, S Abrignani, S Alberti, A Alter, M Bonino, F Bortolotti, F Brechot, C de Moura, MC Carreno, V Colombo, M Craxi, A Davis, G De Francesco, R Degos, F Di Bisceglie, A Dienes, H Dusheiko, G Esteban, J Esteban, R Farci, P Ferrari, C Foster, G Hadziyannis, S Hoofnagle, J Koff, R Lavanchy, D Lindsay, K Lunel, F Manns, M Marcellin, P Mondelli, M Nalpas, B Naoumov, N Pawlotsky, JM Pol, S Pontisso, P Poynard, T Prieto, J Rizzetto, M Roggendorf, M Moreno, MR Samuel, D Sanchez-Tapias, J Schalm, S Shouval, D Simmonds, P Soriano, V Tassopoulos, N Thomas, H Trepo, C Van der Poel, CL Vogel, W Weiland, O Wejstal, R Williams, R Wright, T Zanetti, A Zarski, JP Zeuzem, S Zoulim, F
Citation: P. Marcellin et al., EASL International Consensus Conference on Hepatitis C - Paris, 26-27 February 1999 - Consensus statement (Reprinted from Journal of Hematology, vol 30, pg 956-961, 1999), J HEPATOL, 31, 1999, pp. 3-8
Risultati: 1-15 |